LATEST NEWS
EXACT Therapeutics Announces FDA Clearance of IND for ENACT, a Phase 2 Trial in Pancreatic Cancer
EXACT Therapeutics Receives Investment from GE HealthCare to Advance Therapeutic Ultrasound in Pancreatic Cancer using ACT®
EXACT Therapeutics initiates preclinical immunotherapy collaboration with Agenus Inc.
EXACT Therapeutics announces grant of immunotherapy patent
EXACT Therapeutics has been informed that the Intellectual Property Office in United Kingdom will today grant EXACT its United Kingdom Patent entitled “Enhancement of Treatment with Immunotherapeutic Agents”.
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer